Pulmonary surfactant function following endotoxin: Effects of exogenous surfactant treatment

Shock

Volumn 5, Issue 4, 1996, Pages 304-310

  Picone, Anthony ^a   Gatto, Louis A ^b   Nieman, Gary F ^a   Paskanik, Andrew M ^a   Lutz, Charles ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; LUNG SURFACTANT; SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; INJURY; LUNG; MORTALITY; PATHOLOGY; PHYSIOLOGY; SURFACE TENSION; SWINE;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOPOLYSACCHARIDES; LUNG; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, ADULT; SURFACE TENSION; SURFACE-ACTIVE AGENTS; SWINE;

EID: 0030122503     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199604000-00012     Document Type: Article

References (28)

1. Seeger W, Stohr G, Wolf HRD, Neuhof H: Alteration of surfactant function due to protein leakage: Special interaction with fibrin monomer. J Appl Physiol 58:326-338, 1985.
2. Poison U, Obertacke U, Brand M, et al: Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J Trauma 30:19-26, 1990.
3. Lewis JF, Veldhuizen R, Possmayer F, et al: Altered alveolar surfactant is an early marker of acute lung injury in septic adult sheep. Am J Respir Crit Care Med 150:123-130, 1994.
4. Fuchimukai T, Fujiwara A, Enhorning G: Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 62:429-437, 1987.
5. Ryan SF, Ghassibi Y, Liau DF: Effects of activated polymorphonuclear leukocytes upon pulmonary surfactant in vitro. Am J Respir Cell Mol Biol 4:33-41, 1991.
6. Kobayashi T, Kataoka H, Ueda T, Murakami S, Takeda Y, Kokubo M: Effects of surfactant supplement and end-expiratory pressure in lung lavaged animals. J Appl Physiol 57:995-1001, 1984.
7. Lewis JF, Tabor B, Ikegami M, Jobe A, Joseph M, Absolom D: Lung function and surfactant distribution in saline lavaged sheep given instilled vs. nebulized surfactant. J Appl Physiol 74:1256-1264, 1993.
8. Zelter M, Escudier BJ, Hoeffel JM, Murray JF: Effects of aerosolized artificial surfactant on repeated oleic acid injury in sheep. Am Rev Respir Dis 14:1014-1019, 1990.
9. Lewis J, Ikegami M, Higuchi R, Jobe A, Absolom D: Nebulized vs. instilled exogenous surfactant in an adult lung injury model. J Appl Physiol 71:1270-1276, 1991.
10. 4-receptor antagonist in endotoxin shock: A prospective, controlled trial in a porcine model. Crit Care Med 21:1825-1837, 1993.
11. Lamm WJE, Albert RK: Surfactant replacement improves lung recoil in rabbit lungs after acid aspiration. Am Rev Respir Dis 142:1279-1283, 1990.
12. Theissen JL, Loick HM, Curry BB, Traber DN, Herndon DN, Traber DL: Time course of hypoxic pulmonary vasoconstriction after endotoxin infusion in unanesthetized sheep. J Appl Physiol 70:2120-2125, 1991.
13. Lum H, Mitzner W: A species comparison of alveolar size and surface forces. J Appl Physiol 62:1865-1871, 1987.
14. Nieman GF, Clark WR: Effects of wood and cotton smoke on the surface properties of pulmonary surfactant. Respir Physiol 97:1-12, 1994.
15. Rosenberg E: Analysis of the properties of pulmonary surfactant using modified Wilhelmy balances. Respir Physiol 7:72-87, 1969.
16. Hall SB, Zhong L, Venkitaraman R, Hyde RW, Notter RH: Inhibition of pulmonary surfactant by oleic acid: Mechanisms and characteristics. J Appl Physiol 72:1708-1716, 1992.
17. Notter RH, Taubold R, Mavis RD: Hysteresis in saturated phospholipid films and its potential relevance for lung surfactant function in vivo. Exp Lung Res 3:109-127, 1982.
18. Harris JD, Jackson F, Moxley MA, Longmore WJ: Effect of exogenous surfactant instillation on experimental acute lung injury. J Appl Physiol 66:1846-1851, 1989.
19. Lachmann B, Fujiwara T, Chida S, et al: Surfactant replacement therapy in the experimental adult respiratory distress syndrome (ARDS). In Cosmi EV, Scarpelli, E M (eds): Pulmonary Surfactant System. Amsterdam: Elsevier, 1983, pp 231-235.
20. Berggren P, Lachmann B, Curstedt T, Grossmann G, Robertson B: Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage. Acta Anaesthesiol Scand 30:321-328, 1986.
21. Berry D, Ikegami M, Jobe A: Respiratory distress and surfactant inhibition following vagotomy in rabbits. J Appl Physiol 61:1741-1748, 1986.
22. Martin MA, Silverman HJ: Gram-negative sepsis and the adult respiratory distress syndrome. Clin Infect Dis 14:1213-1228, 1992.
23. Tierney DF, Johnson RP: Altered surface tension of lung extracts and lung mechanics. J Appl Physiol 20:1253-1260, 1965.
24. Holm BA, Notter RH, Finkelstein JN: Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids. Chem Phys Lipids 38:287-298, 1985.
25. King RJ, Clements JA: Surface active materials from dog lung. II. Composition and physiological correlations. Am J Physiol 223:714-726, 1972.
26. Clements JA, Hustead RF, Johnson RP, Gribetz I: Pulmonary surface tension and alveolar stability. J Appl Physiol 16:444-450, 1961.
27. Dantzker DR, Brook CJ, Dehart P, Lynch JP, Weg JG: Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am Rev Respir Dis 120:1039-1052, 1979.
28. Huttemeier PC, Ringsted C, Eliasen K, Mogensen T: Ventilation-perfusion inequality during endotoxin-induced pulmonary vasoconstriction in conscious sheep: Mechanisms of hypoxia. Clin Physiol 8:351-358, 1988.